Green Alpha Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Sell |
565
-103
| -15% | -$45.9K | 0.24% | 89 |
|
|
2025
Q1 | $324K | Sell |
668
-21
| -3% | -$10.2K | 0.35% | 80 |
|
|
2024
Q4 | $277K | Sell |
689
-129
| -16% | -$51.9K | 0.22% | 117 |
|
|
2024
Q3 | $380K | Sell |
818
-69
| -8% | -$32.1K | 0.3% | 102 |
|
|
2024
Q2 | $416K | Sell |
887
-118
| -12% | -$55.3K | 0.33% | 98 |
|
|
2024
Q1 | $420K | Sell |
1,005
-8
| -0.8% | -$3.34K | 0.3% | 108 |
|
|
2023
Q4 | $412K | Sell |
1,013
-179
| -15% | -$72.8K | 0.3% | 117 |
|
|
2023
Q3 | $415K | Sell |
1,192
-651
| -35% | -$226K | 0.32% | 106 |
|
|
2023
Q2 | $649K | Buy |
1,843
+252
| +16% | +$88.7K | 0.43% | 88 |
|
|
2023
Q1 | $501K | Sell |
1,591
-45
| -3% | -$14.2K | 0.35% | 105 |
|
|
2022
Q4 | $472K | Sell |
1,636
-16
| -1% | -$4.62K | 0.39% | 104 |
|
|
2022
Q3 | $478K | Buy |
1,652
+6
| +0.4% | +$1.74K | 0.4% | 111 |
|
|
2022
Q2 | $464K | Sell |
1,646
-1,189
| -42% | -$335K | 0.11% | 129 |
|
|
2022
Q1 | $740K | Buy |
2,835
+109
| +4% | +$28.5K | 0.5% | 83 |
|
|
2021
Q4 | $599K | Buy |
2,726
+63
| +2% | +$13.8K | 0.4% | 100 |
|
|
2021
Q3 | $483K | Buy |
2,663
+265
| +11% | +$48.1K | 0.33% | 118 |
|
|
2021
Q2 | $484K | Buy |
2,398
+479
| +25% | +$96.7K | 0.33% | 120 |
|
|
2021
Q1 | $412K | Buy |
+1,919
| New | +$412K | 0.41% | 89 |
|